Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell ADMA Biologics Inc (ADMA) – ADMA Biologics Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Key Stats

  • Market Cap
    $1.92B
  • Sector
    Health
  • 3M Drawdown
    -52.47%
  • Enterprise Value
    $1.98B
  • Dividend Yield
    -
  • Trading Activity
    94% Buy | 6% Sell
  • Typical Hold Time
    8 days
$8.6
52W Low: $7.88
11 May 2026
52W High: $21.87
11 Jun 2025

ADMA Biologics Inc (ADMA) is currently valued at a market capitalization of $1.92B, with an enterprise value of $1.98B. Over the past 52 weeks, ADMA Biologics Inc has traded between a low of $7.88 and a high of $21.87, highlighting its annual price range. Over the past three months, ADMA Biologics Inc has recorded a drawdown of -52.47%, reflecting recent price volatility. On average, investors hold ADMA Biologics Inc for approximately 8 days, indicating typical investor behavior on the platform.

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.


Technical Indicators
|
|
|
Overall Summary
Bearish (9)Neutral (9)Bullish (9)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $1.92B
  • Sector
    Health
  • 3M Drawdown
    -52.47%
  • Enterprise Value
    $1.98B
  • Dividend Yield
    -
  • Trading Activity
    94% Buy | 6% Sell
  • Typical Hold Time
    8 days
$8.6
52W Low: $7.88
11 May 2026
52W High: $21.87
11 Jun 2025

ADMA Biologics Inc (ADMA) is currently valued at a market capitalization of $1.92B, with an enterprise value of $1.98B. Over the past 52 weeks, ADMA Biologics Inc has traded between a low of $7.88 and a high of $21.87, highlighting its annual price range. Over the past three months, ADMA Biologics Inc has recorded a drawdown of -52.47%, reflecting recent price volatility. On average, investors hold ADMA Biologics Inc for approximately 8 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!